Beavis A D, Lu Y, Garlid K D
Department of Pharmacology, Medical College of Ohio, Toledo 43699-0008.
J Biol Chem. 1993 Jan 15;268(2):997-1004.
Respiring mitochondria drive the electrophoretic uptake of K+ and other cations. In the presence of permeant acids this transport leads to mitochondrial swelling if it is not compensated by electroneutral K+/H+ exchange mediated by the K+/H+ antiporter. The mechanism of influx has yet to be established; however, evidence is accumulating that in addition to leak pathways a specific K+ channel or uniporter may be involved. We examine some of the properties of K+ uniport which are consistent with the existence of a specific ATP-regulated K+ channel. In contrast to the K+/H+ antiporter, K+ uniport shows little dependence on pH. K+ uniport is, however, very sensitive to inhibition by adenine nucleotides. The maximum percent inhibition is increased from 40 to 60% by treatment of mitochondria with N-ethylmaleimide (30 nmol/mg) which stimulates K+ uniport 3.6-fold. N-Ethylmaleimide, however, has no effect on the IC50 values which are 0.5, 2.3, and 8 microM for ADP, ATP, and AMP, respectively. GDP has no effect, while carboxyatractyloside is found to inhibit. The nucleotide analogs Cibacron blue 3GA and erythrosin B exhibit three effects on K+ uniport. Low doses partially inhibit K uniport (I50 = 0.13 microM Cibacron Blue), while higher doses stimulate (EC50 = 13 microM Cibacron Blue). Stimulation is especially apparent in N-ethylmaleimide-treated mitochondria. These analogs also antagonize inhibition by ATP. Since the EC50 values for this antagonism for these two drugs are similar, while the IC50 values for inhibition of ATP transport differ by a factor of five, we suggest that inhibition of K+ uniport by ATP is not mediated via the adenine nucleotide translocase. These data are consistent with the existence of an ATP-regulated K+ channel in the inner mitochondrial membrane.
呼吸的线粒体驱动钾离子(K⁺)和其他阳离子的电泳摄取。在存在渗透性酸的情况下,如果这种转运没有被由K⁺/H⁺反向转运体介导的电中性K⁺/H⁺交换所补偿,就会导致线粒体肿胀。钾离子流入的机制尚未确定;然而,越来越多的证据表明,除了泄漏途径外,可能还涉及一种特定的K⁺通道或单向转运体。我们研究了K⁺单向转运的一些特性,这些特性与存在特定的ATP调节K⁺通道相一致。与K⁺/H⁺反向转运体不同,K⁺单向转运对pH的依赖性很小。然而,K⁺单向转运对腺嘌呤核苷酸的抑制非常敏感。用N - 乙基马来酰亚胺(30 nmol/mg)处理线粒体可使K⁺单向转运增加3.6倍,最大抑制百分比从40%增加到60%。然而,N - 乙基马来酰亚胺对ADP、ATP和AMP的IC50值分别为0.5、2.3和8 μM没有影响。GDP没有作用,而羧基苍术苷被发现具有抑制作用。核苷酸类似物Cibacron blue 3GA和赤藓红B对K⁺单向转运表现出三种作用。低剂量部分抑制K⁺单向转运(Cibacron Blue的I50 = 0.13 μM),而高剂量则刺激(Cibacron Blue的EC50 = 13 μM)。在N - 乙基马来酰亚胺处理的线粒体中,刺激尤为明显。这些类似物还拮抗ATP的抑制作用。由于这两种药物这种拮抗作用的EC50值相似,而抑制ATP转运的IC50值相差5倍,我们认为ATP对K⁺单向转运的抑制不是通过腺嘌呤核苷酸转位酶介导的。这些数据与线粒体内膜中存在ATP调节的K⁺通道一致。